Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.01 and traded as low as C$0.01. Aequus Pharmaceuticals shares last traded at C$0.01, with a volume of 100,000 shares trading hands.
Aequus Pharmaceuticals Price Performance
The company has a current ratio of 0.07, a quick ratio of 0.46 and a debt-to-equity ratio of 138.88. The firm has a market cap of C$663,150.00, a PE ratio of -0.50 and a beta of -0.02. The stock has a 50 day simple moving average of C$0.01 and a 200-day simple moving average of C$0.01.
About Aequus Pharmaceuticals
Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Recommended Stories
- Five stocks we like better than Aequus Pharmaceuticals
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Aequus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aequus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
